Download MendeleyStructure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
Ma, G., Wang, S., Wu, K., Zhang, W., Ahmad, A., Hao, Q., Lei, X., Zhang, H.(2020) Bioorg Med Chem 29: 115902-115902
- PubMed: 33302045
- DOI: https://doi.org/10.1016/j.bmc.2020.115902
- Primary Citation of Related Structures:
6LIP, 6LIZ, 6LJ0, 6LJ1, 6LJ2, 6LJ4, 6LJ5, 6LJ6, 6LJ7, 6LJ8 - PubMed Abstract:
β-lactam antibiotics have long been the mainstay for the treatment of bacterial infections. New Delhi metallo-β-lactamase 1 (NDM-1) is able to hydrolyze nearly all β-lactam antibiotics and even clinically used serine-β-lactamase inhibitors. The wide and rapid spreading of NDM-1 gene among pathogenic bacteria has attracted extensive attention, therefore high potency NDM-1 inhibitors are urgently needed. Here we report a series of structure-guided design of D-captopril derivatives that can inhibit the activity of NDM-1 in vitro and at cellular levels. Structural comparison indicates the mechanisms of inhibition enhancement and provides insights for further inhibitor optimization.
Organizational Affiliation:
Department of Biology, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research and Shenzhen Key Laboratory of Cell Microenvironment, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.
